CLINICAL_TRIALS
trial_result
· 2022-09-19
Clinical Trial Update: ACT-293987 in Pulmonary Arterial Hypertension [Phase 3]
Summary
Phase 3 trial of ACT-293987 in Pulmonary Arterial Hypertension has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2022-09-19